Anteris Technologies Ltd (AVR) - Financial and Strategic SWOT Analysis Review
Anteris Technologies Ltd (AVR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
Anteris Technologies Ltd, (Anteris Technologies), formerly Admedus Ltd develops, manufactures and distributes medical devices and technologies with focus on tissue engineering and immunotherapies. The company’s product portfolio includes ADAPT technology, a next generation bioscaffold that reengineers xenograft tissue into a pure collagen scaffold and DurAVR heart valve, a 3D single piece aortic valve that creates a wider valve opening and better blood flow. Anteris Technologies is headquartered in Brisbane, Queensland, Australia.
Anteris Technologies Ltd Key Recent Developments
Jun 03,2021: Anteris receives $1.49m research and development tax incentive refund
Apr 22,2021: Anteris Technologies announces quarterly activity report for the period to 31 March 2021
Feb 16,2021: Anteris Technologies to Present at the BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference
Jan 22,2021: Anteris Technologies announces quarterly activity report for the period to 31 December 2020
Dec 16,2020: Anteris Technologies : Non-Executive Director resignation
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile contains critical company information including:
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Anteris Technologies Ltd, (Anteris Technologies), formerly Admedus Ltd develops, manufactures and distributes medical devices and technologies with focus on tissue engineering and immunotherapies. The company’s product portfolio includes ADAPT technology, a next generation bioscaffold that reengineers xenograft tissue into a pure collagen scaffold and DurAVR heart valve, a 3D single piece aortic valve that creates a wider valve opening and better blood flow. Anteris Technologies is headquartered in Brisbane, Queensland, Australia.
Anteris Technologies Ltd Key Recent Developments
Jun 03,2021: Anteris receives $1.49m research and development tax incentive refund
Apr 22,2021: Anteris Technologies announces quarterly activity report for the period to 31 March 2021
Feb 16,2021: Anteris Technologies to Present at the BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference
Jan 22,2021: Anteris Technologies announces quarterly activity report for the period to 31 December 2020
Dec 16,2020: Anteris Technologies : Non-Executive Director resignation
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
SECTION 1 - ABOUT THE COMPANY
Anteris Technologies Ltd - Key Facts
Anteris Technologies Ltd - Key Employees
Anteris Technologies Ltd - Key Employee Biographies
Anteris Technologies Ltd - Major Products and Services
Anteris Technologies Ltd - History
Anteris Technologies Ltd - Company Statement
Anteris Technologies Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
SECTION 2 – COMPANY ANALYSIS
Company Overview
Anteris Technologies Ltd - Business Description
Business Segment: Operations
Overview
Performance
Business Segment: Projects
Overview
Performance
Anteris Technologies Ltd - SWOT Analysis
SWOT Analysis - Overview
Anteris Technologies Ltd - Strengths
Anteris Technologies Ltd - Weaknesses
Anteris Technologies Ltd - Opportunities
Anteris Technologies Ltd - Threats
Anteris Technologies Ltd - Key Competitors
SECTION 3 – COMPANY FINANCIAL RATIOS
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES
Anteris Technologies Ltd, Medical Equipment, Deals By Year, 2015 to YTD 2021
Anteris Technologies Ltd, Medical Equipment, Deals By Type, 2015 to YTD 2021
Anteris Technologies Ltd, Recent Deals Summary
SECTION 5 – COMPANY’S RECENT DEVELOPMENTS
Jun 03, 2021: Anteris receives $1.49m research and development tax incentive refund
Apr 22, 2021: Anteris Technologies announces quarterly activity report for the period to 31 March 2021
Feb 16, 2021: Anteris Technologies to Present at the BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference
Jan 22, 2021: Anteris Technologies announces quarterly activity report for the period to 31 December 2020
Dec 16, 2020: Anteris Technologies : Non-Executive Director resignation
Oct 16, 2020: Anteris Technologies : Quarterly activity report fot the period to 30 september 2020
Oct 15, 2020: Anteris Technologies : extended facility agreement with SIO Partners
Aug 31, 2020: Tavr Medical advisory board bppointment
Jul 09, 2020: Anteris Technologies to host TAVR key opinion leader symposium moderated by Matt Miksic of Credit Suisse on July 20th, 2020
Jul 02, 2020: Anteris operations update
SECTION 6 – APPENDIX
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
Anteris Technologies Ltd - Key Facts
Anteris Technologies Ltd - Key Employees
Anteris Technologies Ltd - Key Employee Biographies
Anteris Technologies Ltd - Major Products and Services
Anteris Technologies Ltd - History
Anteris Technologies Ltd - Company Statement
Anteris Technologies Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
SECTION 2 – COMPANY ANALYSIS
Company Overview
Anteris Technologies Ltd - Business Description
Business Segment: Operations
Overview
Performance
Business Segment: Projects
Overview
Performance
Anteris Technologies Ltd - SWOT Analysis
SWOT Analysis - Overview
Anteris Technologies Ltd - Strengths
Anteris Technologies Ltd - Weaknesses
Anteris Technologies Ltd - Opportunities
Anteris Technologies Ltd - Threats
Anteris Technologies Ltd - Key Competitors
SECTION 3 – COMPANY FINANCIAL RATIOS
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES
Anteris Technologies Ltd, Medical Equipment, Deals By Year, 2015 to YTD 2021
Anteris Technologies Ltd, Medical Equipment, Deals By Type, 2015 to YTD 2021
Anteris Technologies Ltd, Recent Deals Summary
SECTION 5 – COMPANY’S RECENT DEVELOPMENTS
Jun 03, 2021: Anteris receives $1.49m research and development tax incentive refund
Apr 22, 2021: Anteris Technologies announces quarterly activity report for the period to 31 March 2021
Feb 16, 2021: Anteris Technologies to Present at the BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference
Jan 22, 2021: Anteris Technologies announces quarterly activity report for the period to 31 December 2020
Dec 16, 2020: Anteris Technologies : Non-Executive Director resignation
Oct 16, 2020: Anteris Technologies : Quarterly activity report fot the period to 30 september 2020
Oct 15, 2020: Anteris Technologies : extended facility agreement with SIO Partners
Aug 31, 2020: Tavr Medical advisory board bppointment
Jul 09, 2020: Anteris Technologies to host TAVR key opinion leader symposium moderated by Matt Miksic of Credit Suisse on July 20th, 2020
Jul 02, 2020: Anteris operations update
SECTION 6 – APPENDIX
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
LIST OF TABLES
Anteris Technologies Ltd, Key Facts
Anteris Technologies Ltd, Key Employees
Anteris Technologies Ltd, Key Employee Biographies
Anteris Technologies Ltd, Major Products and Services
Anteris Technologies Ltd, History
Anteris Technologies Ltd, Subsidiaries
Anteris Technologies Ltd, Key Competitors
Anteris Technologies Ltd, Ratios based on current share price
Anteris Technologies Ltd, Annual Ratios
Anteris Technologies Ltd, Annual Ratios (Cont...1)
Anteris Technologies Ltd, Interim Ratios
Anteris Technologies Ltd, Medical Equipment, Deals By Year, 2015 to YTD 2021
Anteris Technologies Ltd, Medical Equipment, Deals By Type, 2015 to YTD 2021
Anteris Technologies Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
Anteris Technologies Ltd, Key Facts
Anteris Technologies Ltd, Key Employees
Anteris Technologies Ltd, Key Employee Biographies
Anteris Technologies Ltd, Major Products and Services
Anteris Technologies Ltd, History
Anteris Technologies Ltd, Subsidiaries
Anteris Technologies Ltd, Key Competitors
Anteris Technologies Ltd, Ratios based on current share price
Anteris Technologies Ltd, Annual Ratios
Anteris Technologies Ltd, Annual Ratios (Cont...1)
Anteris Technologies Ltd, Interim Ratios
Anteris Technologies Ltd, Medical Equipment, Deals By Year, 2015 to YTD 2021
Anteris Technologies Ltd, Medical Equipment, Deals By Type, 2015 to YTD 2021
Anteris Technologies Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
LIST OF FIGURES
Anteris Technologies Ltd, Performance Chart (2016 - 2020)
Anteris Technologies Ltd, Ratio Charts
Anteris Technologies Ltd, Medical Equipment, Deals By Year, 2015 to YTD 2021
Anteris Technologies Ltd, Medical Equipment, Deals by Type, 2015 to YTD 2021
Anteris Technologies Ltd, Performance Chart (2016 - 2020)
Anteris Technologies Ltd, Ratio Charts
Anteris Technologies Ltd, Medical Equipment, Deals By Year, 2015 to YTD 2021
Anteris Technologies Ltd, Medical Equipment, Deals by Type, 2015 to YTD 2021